Clinical Trials Browser

Adenocarcinoma × enzalutamide × 90 days × Clear all

NCT07592910 2026-05-18

MOMENT

Phase 2 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT06844383 2026-04-24

TALENT

Phase 2 Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT06592924 2026-04-14

TRIPLE-SWITCH

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms